If someday delcath has world wide revenue of $150 million, then it has a place with the big boys on a small scale. My guess maybe 2026 if fda approval for icc in 2025.
Right now I think the industry assigns a value to company of exactly ZERO, there are better fish in the sea at this time. This is no Hercules, that is my analysis, and in the mean time there can be no respect until company shows it gets towards something more tangible than what Europe shows, ie phase 3 completion.
News 
Market Data 
Discover 
